OnPoint Pharma Expert Assists End-Payor Class Cert Against Ranbaxy
On May 14, 2021, U.S. District Judge Nathaniel M. Gorton, sitting in Massachusetts, certified a class of End-Payor Plaintiffs (EPPs) consisting of Third-Party Payors (TPPs) in antitrust and RICO litigation involving applications to produce generic versions of three drugs. Plaintiffs allege that Defendants Ranbaxy and Sun Pharmaceutical conspired to acquire and misuse the exclusivity periods…